机译:Eμ-TCL1小鼠代表慢性淋巴细胞白血病诱导的T细胞功能障碍的免疫治疗逆转模型
Departments of Medical Oncology, The Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115;
Institute of Cancer, Barts and London School of Medicine, University of London, London EC1M 6BQ, United Kingdom;
Departments of Medical Oncology, The Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115;
Departments of Biostatistics and Computational Biology, The Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115;
Institute of Cancer, Barts and London School of Medicine, University of London, London EC1M 6BQ, United Kingdom;
Departments of Biostatistics and Computational Biology, The Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115;
Departments of Biostatistics and Computational Biology, The Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115;
Department of Molecular Virology, Immunology, and Medical Genetics, Ohio State University, Columbus, OH 43210;
Institute of Cancer, Barts and London School of Medicine, University of London, London EC1M 6BQ, United Kingdom;
机译:TCL1转基因小鼠作为CD49D高慢性淋巴细胞白血病的模型
机译:PKCbeta对于TCL1转基因小鼠模型中慢性淋巴细胞性白血病的发展至关重要:验证PKCbeta作为慢性淋巴细胞性白血病的治疗靶标。
机译:TBET表达Th1 CD4 + + T细胞积聚在慢性淋巴细胞白血病中,而不会影响Eμ-TCl1小鼠的疾病进展
机译:慢性淋巴细胞白血病疾病轨迹动态建模的个性化框架
机译:模拟小鼠的下颌功能转变和所产生的颞下颌关节功能障碍
机译:Eμ-TCL1小鼠代表慢性淋巴细胞白血病诱导的T细胞功能障碍的免疫治疗逆转模型
机译:Eμ-TCL1小鼠代表慢性淋巴细胞白血病诱导的T细胞功能障碍的免疫治疗逆转模型